Α,N,N-TMT

drugbox
IUPAC_name = (2-(1H-indol-3-yl)-1-methyl-ethyl)dimethylamine


width = 140
imagename = α,N,N-TMT
CAS_number =
ATC_prefix =
ATC_suffix =
PubChem =
C=13 | H=18 | N=2
molecular_weight = 202.30 g/mol
smiles =
melting_point =
melting_high =
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category =
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Alpha,"N","N"-trimethyltryptamine (α,N,N-TMT; α-TMT) is a tryptamine derivative that is a hallucinogenic drug. It is similar in structure to other hallucinogenic tryptamines such as DMT and AMT.

α-TMT has been animal tested in comparison with AMT, and was found to produce similar effects to AMT but is only around half as potent. [Kalir A, Szara S. Synthesis and pharmacological activity of alkylated tryptamines."Journal of Medicinal Chemistry". 1966 May;9(3):341-4.] Anecdotal reports from human users suggest that it produces psychedelic effects similar to those of other tryptamine derivatives when taken orally at a dose of around 80–120 mg, however it does not appear to have been widely sold or used, and its safety profile has not been studied.

References